State Street Corp Alkermes Plc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Alkermes Plc. stock. As of the latest transaction made, State Street Corp holds 9,003,913 shares of ALKS stock, worth $211 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,003,913
Previous 9,352,970
3.73%
Holding current value
$211 Million
Previous $259 Million
6.06%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$683 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$472 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$348 Million0.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$195 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY6.05MShares$142 Million2.63% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.84B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...